Abstract
Abstract The quantitative determination of the urinary ribonucleosides m1Ado, m22Guo and t6Ado of breast cancer patients was performed by use of an automated high performance liquid chromatography analyzer with on-line sample processing and analysis by a dual column switching technique. M22Guo and t6Ado showed elevated excretion values (normalized to creatinine) in all of our 24 perioperatively examined breast cancer patients. Studies of these two urinary ribonucleosides 3 years after primary surgery showed markedly reduced excretion values in case that no relapse had occurred.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
